Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „studies“
Suchtreffer
Begriffe & Kennungen
Anzupgo · 4.8 · Table 1 lists the adverse reactions that were observed in clinical studies. The adverse reactions are presente
Eintrag öffnenApexelsin · 4.5 · Paediatric population Interaction studies have only been performed in adults.
Eintrag öffnenApidra · 4.5 · Studies on pharmacokinetic interactions have not been performed. Based on empirical knowledge from similar med
Eintrag öffnenApidra · 4.8 · Tabulated list of adverse reactions The following related adverse reactions from clinical studies were listed
Eintrag öffnenApixaban Accord · 4.5 · 44 Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the
Eintrag öffnenApixaban Accord · 4.5 · Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the ac
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · Interaction studies have not been performed in paediatrics.
Eintrag öffnenApixaban Accord · 4.5 · Interaction studies have not been performed in paediatrics. The above mentioned interaction data was obtained
Eintrag öffnenApixaban Accord · 4.8 · 13 In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6%
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the VTEp studies, in total, 11% of the patients treated with apixaban 2.5 mg twice daily experienced advers
Eintrag öffnenApixaban Accord · 4.8 · In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6% in
Eintrag öffnenApixaban Accord · 4.8 · The safety of apixaban has been investigated in 1 Phase I and 3 Phase II/III clinical studies including 970 pa
Eintrag öffnenApixaban Accord · 4.8 · The safety of apixaban has been investigated in 1 Phase I and 3 Phase II/III clinical studies including 970 pa
Eintrag öffnenApretude · 4.5 · No drug interaction studies have been performed with cabotegravir injection. The drug interaction data provide
Eintrag öffnenApretude · 4.5 · Paediatric population Interaction studies have only been performed in adults
Eintrag öffnenApretude · 4.5 · Paediatric population Interaction studies have only been performed in adults.
Eintrag öffnen